Prognostic impact of sarcopenia in patients with hepatocellular carcinoma treated with PD-1 inhibitor.

Yusheng Guo,Yanqiao Ren,Feihong Wu,Xiangjun Dong,Chuansheng Zheng

Therapeutic advances in gastroenterology（2022）

引用 1|浏览6

暂无评分

摘要

HCC patients with sarcopenia tended to have higher levels of inflammation and lower levels of albumin than patients without sarcopenia. Sarcopenia is associated with a shorter PFS in HCC patients treated with PD-1 inhibitor.

查看译文

关键词

hepatocellular carcinoma,immune checkpoint inhibitor,immunotherapy,programmed cell death 1 inhibitor,sarcopenia,skeletal muscle index

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要